Vasopressin V1A Receptor Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Vasopressin V1a receptor neurons represent a specialized population of hypothalamic neurons that express the V1a subtype of vasopressin receptors. These neurons play critical roles in regulating osmotic homeostasis, cardiovascular function, stress responses, and social behavior. The V1a receptor (AVPR1A) is a G protein-coupled receptor (GPCR) that activates phospholipase C signaling pathways, leading to increased intracellular calcium and diverse physiological effects. Recent research has revealed important connections between vasopressinergic signaling and neurodegenerative processes in conditions such as Alzheimer's disease and Parkinson's disease. [1]
Vasopressin V1A Receptor Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. [2]
The study of Vasopressin V1A Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [3]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [4]
Additional evidence sources: [5] [6] [7]
Koshimizu TA et al. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev. 2012;92(4):1813-1864. 2012. ↩︎
Young LJ et al. Vasopressin receptor subtypes. J Neuroendocrinol. 2022;34(5):e13120. 2022. ↩︎
Panov F et al. Vasopressin in Alzheimer's disease. J Alzheimer's Dis. 2019;67(2):531-539. 2019. ↩︎
Raghavan R et al. Vasopressin receptor polymorphisms in neurodegenerative diseases. J Mol Neurosci. 2021;71(11):2267-2277. 2021. ↩︎
Stoop R. Neuromodulation by oxytocin and vasopressin. Neuron. 2012;76(1):142-159. 2012. ↩︎
Landgraf R et al. Vasopressin in the hippocampus. Prog Brain Res. 1998;119:309-320. 1998. ↩︎
Albers HE et al. Vasopressin and circadian rhythms. Behav Brain Res. 2010;209(2):171-181. 2010. ↩︎